Dr. Swapna Goday, M.D, MPH

Dr. Goday is board certified in Hematology and Oncology with several years of clinical experience. She has a passion for patients with breast cancer and also treats all other solid tumors (GI, GU, lung, prostate), bleeding and clotting disorders, and malignant hematology. Having served as the Medical Director for an AntiCoagulation clinic, she also developed a special interest in benign hematology. Dr. Goday has participated in multiple clinical trials at the national level and is a member of the American College of Physicians, the American Society of Hematology, the American Society of Clinical Oncology, and the Texas Medical Association.

Dr. Goday is extremely happy to be a part of the Choice Cancer Care team and believes in the multidisciplinary approach that our team provides. She provides compassionate care for the patients and their families during the most difficult times and helps navigate them with the best treatment course possible. Communication with patients and their families and involving them in the decision-making process helps her tailor the best treatment approach for their diagnosis. This communication is key in managing the oncology care of cancer patients with complex medical issues. Dr. Goday collaborates closely with patients and their referring physicians when coordinating care and corresponds with them directly on her cell phone.

Outside of work, Dr. Goday loves to spend time with her husband and two sons who keep her very busy. She also enjoys traveling, running, baking, and volunteering for community activities. Dr.Goday is fluent in English, Hindi, and Telugu and is currently accepting new patients.

Summary

  • Board certified in Hematology and Oncology with 7+ years of clinical experience.
  • Focused interest in Solid tumors (Breast, GI, GU), Hemostasis & Thrombosis, Malignant
    Hematology.
  • Active Texas Medical License.

Professional Experience & Academic Appointments

  • Medical Oncologist
     Choice Cancer Care, Southlake TX
Sept 2019 – Present
  • Assistant Professor, Hematology Oncology
    University of Texas Southwestern Medical Center, Dallas,TX
Jun 2018 –Aug 2019
  • Assistant Professor, Hematology Oncology
    Temple University School of Medicine
    Allegheny Health Network, Pittsburgh, PA
    Affiliated with Temple University/Drexel University
Aug 2012 –May 2018
  • Medical Director
    WPH Anticoagulation Management Center, Pittsburgh, PA
Nov 2013-May 2018

Education

  • Fellowship, Hematology Oncology 
    Allegheny General Hospital/Western Pennsylvania Hospital Medical Education
    Consortium, Pittsburgh, PA
    Affiliated with Temple University/Drexel University
July 2009 – June 2012
  • Internal Medicine Residency 
    Western Pennsylvania Hospital, Pittsburgh, PA
July 2006–June 2009
  • Master of Public Health (MPH) 
    Major: Health Administration
    Eastern Tennessee State University (ETSU), Johnson City, TN
Jan 2005- May 2006
  • Bachelor of Medicine and Bachelor of Surgery (M.B.B.S) 
    Osmania Medical College, Hyderabad, India
Jan 1998-Sept 2003

Board Certification

  • Board Certified in Medical Oncology, October 2012
  • Board Certified in Hematology, October 2012
  • American Board of Internal Medicine Certified, Sept. 2009
  • ECFMG Certification, Feb. 2005

Medical Licensure

  • Texas Medical License, Active, R2342
  • California Medical License, Inactive, MD147639
  • Pennsylvania Medical License, Inactive, MD437716
  • Federal DEA, Active

Honors and Awards

  • CALGB Summer Group Meeting, 2011 Travel Grant, Boston, MA June 2011
  • Novo-Nordisk Fellowship Grant: HTRS (Hemophilia and Thrombosis Research Society)
    Coagulation Disorders Workshop, Orlando, Florida December 2, 2010
  • Novo-Nordisk Fellowship Grant: HTRS (Hemophilia and Thrombosis Research Society)
    Coagulation Disorders Workshop, Diagnosis and Management of Coagulation Disorders
    on April 21, 2009, at San Diego, California.
  • Gold Medal in Microbiology in 2000 for outstanding performance.
  • First Division Honors in Medical school
  • First Division in Pharmacology, Microbiology, Pathology, Forensic Medicine, ENT,
    Ophthalmology, Gynecology and Obstetrics, Medicine and Pediatrics in MBBS.
  • Received certificate of Merit awarded by the Ministry of Human Resources &
    Development, Government of India as a part of National Scholarship Scheme in 1997-98

Additional Appointments

  • Co-Director 
    Breast Cancer curriculum, UTSW Medical School, Dallas, TX
Aug 2018-Aug 2019
  • Duty Medical Officer 
    Poulomi Hospitals, Hyderabad, India
July 2003-Dec 2004
  • Internal Medicine House Officer 
    Department of Medicine
    Osmania General Hospital, Hyderabad, India
July 2002 –June 2003

Committee Memberships

  • Medical Director
    WPH Anticoagulation Management Center
Nov 2013-May 2018
  • Education Committee Member
    Society for the Advancement of Blood Management
Nov 2015- May 2018
  • Transfusion Committee Member
    Allegheny Health Network, Pittsburgh, PA
Aug 2015-May 2018
  • Anticoagulation Committee Member
    Allegheny Health Network, Pittsburgh, PA
Aug 2013-May 2018
  • Cancer Committee Member
    Western Pennsylvania Hospital, Pittsburgh, PA
Jan 2014- May 2018

Professional Society Memberships

  • Texas Medical Association
  • American Society of Hematology, Associate Member
  • American Society of Clinical Oncology, Associate Member
  • Member of International Society on Thrombosis and Hemostasis (ISTH)
  • American College of Physicians
  • American Medical Association
  • MPH Student Association ETSU Alumni

Presentations

  • Hepatocellular carcinoma presenting as an atrial mass; S. Goday., A. Achilleos, K. Foust,
    C. Herb – Western Pennsylvania ACP Chapter Scientific Meeting Nov. 8, 2008.
  • Pseudoaneurysm of the Superior Gluteal Artery occurring as a complication of Bone
    marrow Biopsy; A. Sinha, S. Goday, A. Achilleos – Western Pennsylvania ACP Chapter
    Scientific Meeting Nov. 8, 2008.
  • EBV infection masquerading as Behcet’s disease; S. Goday, R. Volosky, A. Achilleos –
    Western Pennsylvania ACP Chapter Scientific Meeting Nov. 8, 2008.
  • Spinal Neurosarcoidosis; S. Goday, A. Achilleos, S. Komerally, R. Arora- Western
    Pennsylvania ACP Chapter Scientific Meeting Nov. 8, 2008.
  • Clinical Vignette Presentation, May 15, 2009 – Spinal Neurosarcoidosis at Society of
    General Internal Medicine (SGIM) at Florida.
  • Medical Jeopardy Competition – Participant in ACP Medical Jeopardy Pennsylvania
    Chapter Scientific Meeting, Dec. 2008.

Research

  • Co-Investigator: Discovery of targetable somatic alterations in drug resistant Triple
    Negative Breast Cancer after Neoadjuvant chemotherapy-UT Southwestern Medical
    Center, 2018-19
  • Co-Investigator: S1207 :Phase III Randomized ,Placebo –Controlled Clinical Trial
    Evaluating the Use of Adjuvant Endocrine Therapy +/- One year of Everolimus in Patients
    with High Risk Hormone Receptor Positive and Her2/neu Negative Breast Cancer-UT
    Southwestern Medical Center, 2018-19.
  • Co-Investigator: NSABP B-51 A Randomized Phase III Clinical Trial Evaluating Post
    Mastectomy Chest Wall and Regional Nodal XRT and Post Lumpecomy Regional Nodal
    XRT and Post Lumpectomy Regional Nodal XRT in patients with Positive Axillary Nodes
    before Neoadjuvant Chemotherapy who convert to Pathologically Negative Axillary
    Nodes After Neoadjuvant Chemotherapy- UT Southwestern Medical Center, 2018-19.
  • Co-Investigator: Tailor RT A Randomized Trial of Regional Radiotherapy in Biomarker
    Low Risk Node Positive Breast Cancer – UT Southwestern Medical Center, 2018-19.
  • Co-Investigator: A Phase 3 Randomized Study of Margetuximab Plus Chemotherapy vs
    transtuzumab Plus Chemotherapy in the Treatment of Patients with HER2 positive
    Metastatic Breast Cancer who have received prior Anti Her2 therapies and Require
    Systemic Treatment- UT Southwestern Medical Center, 2018-19.
  • Co-Investigator: Pre Surgical trial of Letrozole in Post-Menopausal Patients with
    Operable Hormone Sensitive Breast Cancer- UT Southwestern Medical Center, 2018-19.
  • Co-Investigator: MonarchE: Protocol 13 Y-MC-JPCF: A Randomized Open Label ,Phase3
    Study of Abemaciclib Combined with Standard Adjuvant Endocrine Therapy versus
    Standard Adjuvant Endocrine Therapy Alone in Patients with High Risk Node Positive, Early Stage Hormone Receptor positive ,Her2 Negative Breast Cancer – UT Southwestern Medical Center, 2018-19.
  • Co-Investigator: EA1131 : A Randomized Phase III PostOperative Trial of Platinum Based
    Chemotherapy vs Capecitabine in patients with Residual Triple Negative Breast cancer
    following Neoadjuvant Chemotherapy- UT Southwestern Medical Center, 2018-19.
  • Co-Investigator: A011106 :ALTernate approaches for clinical Stage II or III Estrogen
    Receptor positive Breast Cancer NeoAdjuvant TrEatment( ALTERNATE) in postmenopausal
    women .A Phase III Study- UT Southwestern Medical Center, 2018-19.
  • Co-Investigator: Comparison of Operative to Monitoring and Endocrine Therapy
    (COMET) Trial for Low Risk DCIS : A Phase III Prospective Randomized Trial -UT
    Southwestern Medical Center, 2018-19.
  • Co-Investigator: A Phase III Randomized Double blind Study to Evaluate Pembrolizumab
    Plus Chemotherapy vs Placebo plus Chemotherapy as Neoadjuvant therapy and
    Pembrolizumab vs Placebo as Adjuvant Therapy For Triple Negative Breast Cancer.
    UT Southwestern Medical Center, 2018-19.
  • Site Principal Investigator : ATTRACT Study ( NIH Funded) in colloboration with
    Washington University School of Medicine: Acute Venous Thrombosis –Thrombus
    removal with adjunctive catheter directed Thrombolysis .Final results published in NEJM
    -Dec 2017.
  • Site Principal Investigator: BRIDGE Study ( NIH ,National Heart ,lung and Blood Institute
    funded) in colloboraton with Duke Clinical Research Institute :Bridging Anticoagulation
    in patients who require temporary interruption of warfarin therapy for an elective
    invasive procedure or therapy-Final results published in NEJM – August 2015.
  • Site Principal Investigator: Comparison of Oral anticoagulants for extended VEnous
    Thromboembolism (COVET) in collaboration with Duke Clinical Research Institute
    Principal Investigator: Thomas Ortel, MD Co-Principal Investigator: Lana Castellucci, MD
    Co-Principal Investigator: David Garcia, MD.
  • Co-Investigator:Alliance Venous Thromboembolism-Clincal Trial–Direct Oral
    Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer (CANVAS)-A
    Randomized Effectiveness Trial.
  • Principal Investigator: Retrospective analysis of indications of IVC filter placement at
    Allegheny Health Network –Presented at local chapter –PSOH (Pennsylvania Soceity of
    Oncology and Hematology).

Publications

  • Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis
    Suresh Vedantham, MD etal. ATTRACT investigators. N Engl J Med. Dec 7, 2017
    ;377:2240-2252.
  • Using Smartphones to Access Medical Reference Information.
    Swapna Goday MD, MPH Onc Live, Published September 12, 2011.
  • An extremely rare case of pancreatic cancer presenting with leptomeningeal
    carcinomatosis and synchronous intraparenchymal brain metastasis.
    Gastrointestinal Cancer Research 2013 May-Jun; 6(3): 90–92 Rohit rao, Santosh K
    Sadashiv, Swapna Goday, Dulabh Monga.
  • Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
    Douketis JD, Spyropoulos AC, Kaatz S, Becker RC, Caprini JA, Dunn AS, Garcia DA, Jacobson
    A, Jaffer AK, Kong DF, Schulman S, Turpie AG, Hasselblad V, Ortel TL; BRIDGE
    Investigators. N Engl J Med. 2015 Aug 27;373(9):823-33.

More Choice Cancer Care Centers